Overview
Beacon Biosignals applies machine learning to EEG data to deliver scalable neural biomarkers for clinical trials and neurology applications. Their Dreem headband and cloud analytics platform help pharma companies measure brain activity endpoints at scale.
More in Neurodiagnostics
Latest industry news
BlueWind Medical's Revi Extend Wins FDA Clearance, Extending Implant Life to 15 Years
2026-08-06 · Product
Neurofeedback Systems Market Eyes $2.95 Billion Valuation by 2035 as Clinical and Consumer Demand Converge
2026-08-05 · Industry
Smaller Neuromodulation Devices Are Reshaping the Competitive Landscape for TMS Providers
2026-08-04 · Industry
NIH-Backed Brain-Computer Device Restores Speech in Paralyzed Patient
2026-08-03 · Research
Company details
Category
🔬 Neurodiagnostics
Location
Boston, USA
Funding
Series B · $45M
Website
beacon.bioListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →